TD Cowen Initiates Coverage of MDxHealth With Outperform Rating
Analyst Dan Brennan wrote in a note to investors that the company's position in an under-penetrated market bodes well for future revenue growth.
In Brief This Week: Biocept, Quest, Agilent, MDxHealth, OpGen, More
News items for the week of May 15, 2023.
Medicare Covering Epic Sciences ctDNA Breast Cancer Panel, MDxHealth's Select MDx Test
Medicare is covering the 56-gene ctDNA panel that forms one component of the DefineMBC multiomic liquid biopsy test.
Prominent players in the market cited maturing validity data and updated guidelines that have led to growing awareness among doctors and patients.
William Blair Initiates Coverage of MDxHealth With Outperform Rating
A letter to investors noted the company's dedicated focus on prostate cancer diagnostics, which de-risks the firm's growth outlook and path to profitability.
Feb 3, 2023
MDxHealth Prices $40M Public Offering
Oct 21, 2021
MDxHealth Q3 Revenues Grow 23 Percent
Mar 3, 2021